Aurobindo Pharma Limited

DecreasedQuarterly

AUROPHARMAPharmaceuticalsMarket Cap₹100K Cr

Stake

3.20% → 0.00%

HDFC Mutual Fund

Mutual Fund

The move

HDFC Mutual Fund fully exited Aurobindo Pharma, selling its remaining 1.82 crore shares worth ₹2,790 Cr. This reduced its stake from 3.20% to 0.00%.

About Aurobindo Pharma Limited

Visit stock

A major manufacturer of active pharmaceutical ingredients and generic pharmaceuticals, Aurobindo Pharma produces a diverse range of pharmaceutical products serving domestic and international markets. The company operates across multiple therapeutic segments and maintains manufacturing facilities that comply with global quality standards. Its vertically integrated operations, coupled with significant research and development capabilities, distinguish it as a key player in India's pharmaceutical sector.

About HDFC Mutual Fund

Visit investor

One of India's oldest and most trusted AMCs with over Rs 7.5 lakh crore in AUM. Founded in 1999 as a joint venture between HDFC Bank and Standard Life. MD and CEO Navneet Munot, formerly CIO of SBI MF, has reinforced the quality and compounding philosophy across equity schemes. HDFC Flexi Cap Fund and HDFC Mid-Cap Opportunities Fund are among the largest actively managed equity schemes in India.

Get the next move the moment it happens.

Follow HDFC Mutual Fund and Aurobindo Pharma Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Aurobindo Pharma Limited shareholders HDFC Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Aurobindo Pharma Limited

Quant Mutual FundDecreased

Quant Mutual Fund reduced its stake in Aurobindo Pharma by selling 371,210 shares, decreasing its holding from 28,869,269 shares to 28,498,059 shares. The shares were valued at approximately ₹56.96 crore based on the share price of ₹1532.00. Quant Mutual Fund participated in Aurobindo Pharma's buyback, tendering shares at ₹1,475 per share.

26 Jul 2026

Bandhan Mutual FundExited

Bandhan Mutual Fund has dropped off Aurobindo Pharma Limited's disclosed shareholder list, meaning either a complete exit or a reduction of its stake to below the 1 percent reporting threshold.